Cases
Macrocure Ltd. (NASDAQ: MCUR)
Merger
Overview
Overview
- Date:
- 12/8/2016
- Company Name:
- Macrocure Ltd.
- Stock Symbol:
- MCUR
- Company Name - Buyer:
- Leap therapeutics, Inc.
- Class Period:
- FROM 12/6/2016
- Status:
- Closed/Complete
- Merger Announcement Date:
- 8/29/2016
- Court:
- U.S. District Court: Southern District of New York
NEW YORK, December 8, 2016 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the New York Southern District Court on behalf of all persons or entities who held Macrocure Ltd. (NASDAQ: MCUR) securities on December 6, 2016 (the “Class Period”).
On August 29, 2016, the two parties announced the signing of a definitive merger agreement pursuant to which Leap Therapeutics, Inc. will acquire Macrocure Ltd. in a merger in a deal. As a result of the merger, Macrocure shareholders are anticipated to receive newly issued shares of Leap common stock.
The complaint alleges that the company: (1) failed to conduct a fair sales process, (2) failed to disclose how much this proposed transaction undervalues the company, and (3) failed to disclose all material information regarding the sale of the company.
If you held Macrocure securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On August 29, 2016, the two parties announced the signing of a definitive merger agreement pursuant to which Leap Therapeutics, Inc. will acquire Macrocure Ltd. in a merger in a deal. As a result of the merger, Macrocure shareholders are anticipated to receive newly issued shares of Leap common stock.
The complaint alleges that the company: (1) failed to conduct a fair sales process, (2) failed to disclose how much this proposed transaction undervalues the company, and (3) failed to disclose all material information regarding the sale of the company.
If you held Macrocure securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.